Haematologists could consider switching some patients on warfarin to a DOAC in order to reduce the need for INR monitoring and with it, potential patient exposure to COVID-19. The British Society for Haematology’s Haemostasis and Thrombosis task force said in a statement that regular INR monitoring of patients on warfarin was an essential part of ...
Switch from warfarin to DOACs to avoid INR monitoring exposure
By Mardi Chapman and Nicola Garrett
30 Mar 2020